Solid Biosciences Inc expected to post a loss of $1.53 a share - Earnings Preview

Solid Biosciences

07/08/2023 14:33

* Solid Biosciences Inc  SLDB.OQ   SLDB.O  is expected
to show a
fall in quarterly revenue when it reports  results on August 9
(estimated). 
    * The Charlestown Massachusetts-based  company is expected
to
report  a 76.2% decrease in revenue to $1.467 million from $6.17
million a year ago, according to the mean estimate from 3
analysts, based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Solid Biosciences
Inc is
for a loss of $1.53 per share. 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Solid
Biosciences
Inc is $8​, above​ its last closing price of $3.75. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Mar. 31 2023  -2.21       -2.05      -1.50     Beat    26.9
 Dec. 31 2023              -1.65      -2.82     Missed  -70.7
 Sep. 30 2022  -2.57       -2.67      -2.71     Missed  -1.5​
 Jun. 30 2022  -3.07       -3.15      -3.30     Missed  -4.8
 ​​Mar.        -2.77       -2.76      -3.30     Missed  -19.6
 31 2022                                                
 Dec. 31 2021              -2.91      -2.40     Beat    17.5​
 Sep. 30 2021  -2.99       -3.02      -2.40     Beat    20.6
 Jun. 30 2021  -2.80       -2.82      -2.55     Beat    9.7
 This summary was machine generated August 7 at 13:33 GMT.  All
figures in US dollars  unless otherwise stated